T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.81B |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.46B |
| 3 |
Accenture
ACN
|
+$1.23B |
| 4 |
Gilead Sciences
GILD
|
+$1.15B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06B |
| 3 |
Tesla
TSLA
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.72B |
| 5 |
Amazon
AMZN
|
+$1.59B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
W.P. Carey
WPC
$16.3B
| $68.3M | 0.01% |
1,082,219
+23,868
| +2% | +$1.41M |
|
627
Vertiv
VRT
$111B
| $68.1M | 0.01% |
943,617
-1,169,312
| -55% | -$124M |
|
628
Biohaven
BHVN
$2.24B
| $67.9M | 0.01% |
2,822,974
-589,217
| -17% | -$20.8M |
|
629
Option Care Health
OPCH
$3.61B
| $67.9M | 0.01% |
1,941,777
-10,080
| -0.5% | -$316K |
|
630
Constellation Brands
STZ
$23.3B
| $67.8M | 0.01% |
369,417
-1,095,658
| -75% | -$199M |
|
631
Watts Water Technologies
WTS
$12.8B
| $67.7M | 0.01% |
331,871
+772
| +0.2% | +$162K |
|
632
Agios Pharmaceuticals
AGIO
$2B
| $67.4M | 0.01% |
2,301,353
-122,184
| -5% | -$4.05M |
|
633
Disc Medicine
IRON
$3.07B
| $67.4M | 0.01% |
1,358,254
-36,383
| -3% | -$2.02M |
|
634
Douglas Emmett
DEI
$1.99B
| $67.1M | 0.01% |
4,195,729
+492,997
| +13% | +$8.36M |
|
635
Wynn Resorts
WYNN
$10.5B
| $66.7M | 0.01% |
799,247
-18,594
| -2% | -$1.59M |
|
636
Tenaris
TS
$26.6B
| $66.6M | 0.01% |
1,703,658
-171,673
| -9% | -$6.59M |
|
637
UFP Industries
UFPI
$5.03B
| $66.4M | 0.01% |
620,081
-17,338
| -3% | -$1.93M |
|
638
SPX Corp
SPXC
$10.6B
| $66.3M | 0.01% |
514,858
+2,505
| +0.5% | +$359K |
|
639
CorVel
CRVL
$3.25B
| $66.3M | 0.01% |
591,798
-33,814
| -5% | -$3.77M |
|
640
Royal Gold
RGLD
$19.1B
| $66.3M | 0.01% |
405,224
+15,167
| +4% | +$2.22M |
|
641
Payoneer
PAYO
$2.42B
| $65.6M | 0.01% |
8,970,295
+260,306
| +3% | +$2.43M |
|
642
Kroger
KR
$35.1B
| $65.3M | 0.01% |
965,081
+15,125
| +2% | +$959K |
|
643
Post Holdings
POST
$3.65B
| $64.8M | 0.01% |
556,982
+3,338
| +0.6% | +$370K |
|
644
NRG Energy
NRG
$25.2B
| $64.4M | 0.01% |
674,893
-3,001
| -0.4% | -$303K |
|
645
Protagonist Therapeutics
PTGX
$9.8B
| $63.9M | 0.01% |
1,322,006
-70,646
| -5% | -$2.96M |
|
646
Mirum Pharmaceuticals
MIRM
$6.02B
| $63.8M | 0.01% |
1,415,137
-7,592
| -0.5% | -$358K |
|
647
W.W. Grainger
GWW
$62.2B
| $63.6M | 0.01% |
64,401
-46,672
| -42% | -$48.3M |
|
648
Kadant
KAI
$3.91B
| $63.6M | 0.01% |
188,667
-2,730
| -1% | -$992K |
|
649
Americold
COLD
$4.32B
| $63.5M | 0.01% |
2,960,873
+2,783,264
| +1,567% | +$60.5M |
|
650
Rhythm Pharmaceuticals
RYTM
$7.99B
| $63.5M | 0.01% |
1,199,053
+513,901
| +75% | +$28.5M |
|
Similar funds
T. Rowe Price Associates's Q1 2025 Portfolio in Review
As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
- T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
- T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
- T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
- T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
- T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.
Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.